Sobi - North America Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sobi - North America's estimated annual revenue is currently $64.8M per year.(i)
  • Sobi - North America's estimated revenue per employee is $186,178

Employee Data

  • Sobi - North America has 348 Employees.(i)
  • Sobi - North America grew their employee count by 1% last year.

Sobi - North America's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
VP, Head Strategy and Business DevelopmentReveal Email/Phone
3
Head US ImmunologyReveal Email/Phone
4
VP, Business Development and Alliance ManagementReveal Email/Phone
5
VP, Head Strategy and Business OptimizationReveal Email/Phone
6
VP, Customer Experience, Insights and OperationsReveal Email/Phone
7
Executive Director Payer & GPO AccountsReveal Email/Phone
8
Associate Director, Payer Strategy & MarketingReveal Email/Phone
9
Regional Account Director, Market Access-NortheastReveal Email/Phone
10
Associate Director - Commercial Enablement & DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is Sobi - North America?

Sobi is an international specialty healthcare company dedicated to developing treatments and extensive patient support networks for people with rare and difficult to treat diseases. These patients are often misunderstood, misdiagnosed and have limited medical options otherwise. This commitment has led to our world-class capabilities in protein biochemistry and biologics manufacturing, recognized by our leading industry partners. In North America, we have established our home bases in Waltham, MA and Toronto, Canada. Our employees not only have deep expertise in rare diseases, but are also dedicated to listening and learning from patients, payers and HCPs to ensure we're bringing value to the region in the smartest, most impactful ways. Inflammatory and genetic diseases

keywords:N/A

N/A

Total Funding

348

Number of Employees

$64.8M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sobi - North America News

2022-04-20 - Cytokine Release Syndrome Treatment Market Size, Outlook ...

... Incyte Corporation, Jazz pharmaceuticals, Novartis, CytoSorbents, Swedish Orphan Biovitrum (Sobi) ... North America (USA and Canada)

2022-04-06 - Could This Drug Candidate Be a Blockbuster for Sanofi?

Sanofi can sell it in North America and any remaining markets that Sobi hasn't pursued. North America, of course, includes the U.S. market,...

2022-03-30 - Sobi publishes 2021 Annual and Sustainability Report

... immunology and specialty care, Sobi has approximately 1,600 employees across Europe, North America, the Middle East and Asia.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$134.7M34813%N/A
#2
$121.8M36114%N/A
#3
$64.5M363-20%$25.6M
#4
$93.4M3655%N/A
#5
$65.4M368-12%$159.1M